Skip to main content

Peer Review reports

From: Reduced doses of dabrafenib and trametinib combination therapy for BRAF V600E-mutant non-small cell lung cancer prevent rhabdomyolysis and maintain tumor shrinkage: a case report

Original Submission
4 Apr 2019 Submitted Original manuscript
18 May 2019 Reviewed Reviewer Report - Nagio Takigawa
10 Jul 2019 Author responded Author comments - Yuta Adachi
Resubmission - Version 2
10 Jul 2019 Submitted Manuscript version 2
7 Aug 2019 Reviewed Reviewer Report - Nagio Takigawa
4 Feb 2020 Reviewed Reviewer Report - Reviewer 2
7 Feb 2020 Author responded Author comments - Yuta Adachi
Resubmission - Version 3
7 Feb 2020 Submitted Manuscript version 3
Publishing
11 Feb 2020 Editorially accepted
24 Feb 2020 Article published 10.1186/s12885-020-6626-9

You can find further information about peer review here.

Back to article page